COUPLE INFERTILITY
Infertility is defined as the inability to achieve pregnancy after 12 months of regular, unprotected, targeted sexual intercourse.
According to data from the Italian National Institute of Health (Istituto Superiore di Sanità)**¹, infertility affects approximately 15% of couples, with a substantially equal distribution between men and women.
Genetic causes account for approximately:
10–15% of male infertility cases;
8–10% of female infertility cases.
These causes may include chromosomal abnormalities or mutations in specific genes involved in reproductive processes.
In approximately 20% of cases, infertility is classified as idiopathic, meaning that no specific etiological
factor can be identified through standard diagnostic investigations.
¹ Registro Nazionale PMA – Istituto Superiore di Sanità, “Infertilità e tecniche di PMA”, aggiornamento 09/03/2018
WHAT IS FertilAdvance
FERTILADVANCE is a next-generation genetic test designed for the comprehensive evaluation of the genetic causes of male and female infertility in couples experiencing reproductive difficulties.
Through a multigene approach based on high-resolution Next Generation Sequencing (NGS) technology,
FERTILADVANCE enables a comprehensive analysis of the key genes involved in gametogenesis, oocyte maturation, early embryonic development and hormonal regulation.
Clinical Value
Support for etiological diagnosis (reducing the proportion of “idiopathic” infertility)
Reproductive risk stratification
Definition of personalized clinical strategies (ART, targeted PGT when indicated, and family counseling)
DIFFERENT TESTING OPTIONS FOR EVERY CLINICAL NEED
Sample required:
- Peripheral Blood
TECHNOLOGY: HIGH RESOLUTION AND ADVANCED BIOINFORMATICS ANALYSIS
FERTILADVANCE uses Next Generation Sequencing (NGS) technology with complete sequencing of the coding regions (whole exon sequencing) of the genes analyzed, combined with an advanced bioinformatics pipeline.
Advantage compared to targeted tests: rather than searching only for predefined mutations, FertilAdvance
enables the identification of any genetic variant within the sequenced regions, significantly increasing
diagnostic capability
FERTILADVANCE uses Next Generation Sequencing (NGS) technology with complete sequencing of the coding regions (whole exon sequencing) of the genes analyzed, combined with an advanced bioinformatics pipeline.
Advantage compared to targeted tests: rather than searching only for predefined mutations, FertilAdvance
enables the identification of any genetic variant within the sequenced regions, significantly increasing
diagnostic capability
ADVANTAGES OF FertilAdvance
EASY
Sample required:
3 ml peripheral blood
INFORMATIVE
Comprehensive genetic investigation of infertility causes
ADVANCED
State-of-the-art NGS technology and sophisticated bioinformatics analysis
ACCURATE
Sensitivity and specificity
> 99%
Turnaround time:
SIMPLE AND FAST WORKFLOW

Tests entirely performed
in Italy

Over 100,000
genetic tests/year

Available throughout
the Italian territory

Professionals with over 20 years of experience in genetics and molecular biology

Fast
reporting

Dedicated
R&D Team

Laboratories with groundbreaking technologies and high quality standards

Team of
geneticists

International partnerships
and with pharmaceutical companies.
Test interamente eseguiti
in Italia
Over 100,000
genetic tests/year
Available throughout
the Italian territory
Professionals with over 20 years of experience in genetics and molecular biology
Fast
reporting
Dedicated R&D Team
Laboratories with
groundbreaking
technologies and high quality standards
Team of
geneticists
International partnerships
and with pharmaceutical companies.
Request information about FERTILADVANCE test
Fill in this form for a free consultation. One of our geneticists will contact you, free of charge and without obligation, to provide you with all the information you need.


Italiano
English

